These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1070 related items for PubMed ID: 19386350

  • 1. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM, Erdogan S, Vasmatzis G, Yang P, Tillmans LS, Johnson MR, Wang X, Peterson LM, Halling KC, Oliveira AM, Aubry MC, Yi ES.
    Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
    [Abstract] [Full Text] [Related]

  • 2. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
    Lin E, Li L, Guan Y, Soriano R, Rivers CS, Mohan S, Pandita A, Tang J, Modrusan Z.
    Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
    [Abstract] [Full Text] [Related]

  • 3. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
    Wallander ML, Geiersbach KB, Tripp SR, Layfield LJ.
    Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
    [Abstract] [Full Text] [Related]

  • 4. Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.
    Sanders HR, Li HR, Bruey JM, Scheerle JA, Meloni-Ehrig AM, Kelly JC, Novick C, Albitar M.
    Cancer Genet; 2011 Jan; 204(1):45-52. PubMed ID: 21356191
    [Abstract] [Full Text] [Related]

  • 5. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
    Takeuchi K, Choi YL, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Takada S, Yamashita Y, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y, Mano H.
    Clin Cancer Res; 2008 Oct 15; 14(20):6618-24. PubMed ID: 18927303
    [Abstract] [Full Text] [Related]

  • 6. EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.
    Shinmura K, Kageyama S, Tao H, Bunai T, Suzuki M, Kamo T, Takamochi K, Suzuki K, Tanahashi M, Niwa H, Ogawa H, Sugimura H.
    Lung Cancer; 2008 Aug 15; 61(2):163-9. PubMed ID: 18242762
    [Abstract] [Full Text] [Related]

  • 7. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
    Inamura K, Takeuchi K, Togashi Y, Nomura K, Ninomiya H, Okui M, Satoh Y, Okumura S, Nakagawa K, Soda M, Choi YL, Niki T, Mano H, Ishikawa Y.
    J Thorac Oncol; 2008 Jan 15; 3(1):13-7. PubMed ID: 18166835
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
    Yoshida A, Tsuta K, Nakamura H, Kohno T, Takahashi F, Asamura H, Sekine I, Fukayama M, Shibata T, Furuta K, Tsuda H.
    Am J Surg Pathol; 2011 Aug 15; 35(8):1226-34. PubMed ID: 21753699
    [Abstract] [Full Text] [Related]

  • 9. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF, Tong JH, Yeung KS, Lung RW, Law PP, Chau SL, Kang W, Tong CY, Chow C, Chan AW, Leung LK, Mok TS.
    J Thorac Oncol; 2013 Jul 15; 8(7):883-91. PubMed ID: 23625156
    [Abstract] [Full Text] [Related]

  • 10. Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the Detection of Anaplastic Lymphoma Kinase (ALK) and Ros Proto-oncogene 1 (ROS1) Gene Rearrangements in Non-Small Cell Lung Carcinoma: A 4.5-Year Experience Highlighting Challenges and Pitfalls.
    Nambirajan A, Sood R, Khatoon W, Malik PS, Mohan A, Jain D.
    Arch Pathol Lab Med; 2024 Aug 01; 148(8):928-937. PubMed ID: 38054562
    [Abstract] [Full Text] [Related]

  • 11. Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing.
    V Laffert M, Warth A, Penzel R, Schirmacher P, Jonigk D, Kreipe H, Schildhaus HU, Merkelbach-Bruse S, Büttner R, Reu S, Kerler R, Jung A, Kirchner T, Wölfel C, Petersen I, Rodriguez R, Jochum W, Bartsch H, Fisseler-Eckhoff A, Berg E, Lenze D, Dietel M, Hummel M.
    Lung Cancer; 2013 Aug 01; 81(2):200-6. PubMed ID: 23669200
    [Abstract] [Full Text] [Related]

  • 12. ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases.
    Yoshida A, Kohno T, Tsuta K, Wakai S, Arai Y, Shimada Y, Asamura H, Furuta K, Shibata T, Tsuda H.
    Am J Surg Pathol; 2013 Apr 01; 37(4):554-62. PubMed ID: 23426121
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
    Park HS, Lee JK, Kim DW, Kulig K, Kim TM, Lee SH, Jeon YK, Chung DH, Heo DS.
    Lung Cancer; 2012 Aug 01; 77(2):288-92. PubMed ID: 22465695
    [Abstract] [Full Text] [Related]

  • 14. Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?
    Yamamoto M, Takeuchi K, Shimoji M, Maniwa T, Isaka M, Nakagawa K, Ohde Y, Kondo H, Nakajima T.
    Cancer Sci; 2012 Feb 01; 103(2):390-2. PubMed ID: 22296236
    [Abstract] [Full Text] [Related]

  • 15. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
    Achcar Rde O, Nikiforova MN, Dacic S, Nicholson AG, Yousem SA.
    Hum Pathol; 2009 Jun 01; 40(6):854-60. PubMed ID: 19269006
    [Abstract] [Full Text] [Related]

  • 16. The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.
    Betz BL, Dixon CA, Weigelin HC, Knoepp SM, Roh MH.
    Cancer Cytopathol; 2013 Sep 01; 121(9):489-99. PubMed ID: 23536384
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.
    Takahashi T, Sonobe M, Kobayashi M, Yoshizawa A, Menju T, Nakayama E, Mino N, Iwakiri S, Sato K, Miyahara R, Okubo K, Manabe T, Date H.
    Ann Surg Oncol; 2010 Mar 01; 17(3):889-97. PubMed ID: 20183914
    [Abstract] [Full Text] [Related]

  • 18. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
    Kelleher FC, McDermott R.
    Eur J Cancer; 2010 Sep 01; 46(13):2357-68. PubMed ID: 20451371
    [Abstract] [Full Text] [Related]

  • 19. A novel EML4-ALK variant: exon 6 of EML4 fused to exon 19 of ALK.
    Penzel R, Schirmacher P, Warth A.
    J Thorac Oncol; 2012 Jul 01; 7(7):1198-9. PubMed ID: 22706607
    [Abstract] [Full Text] [Related]

  • 20. Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer.
    Kijima T, Takeuchi K, Tetsumoto S, Shimada K, Takahashi R, Hirata H, Nagatomo I, Hoshino S, Takeda Y, Kida H, Goya S, Tachibana I, Kawase I.
    Cancer Sci; 2011 Aug 01; 102(8):1602-4. PubMed ID: 21767331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.